BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34622970)

  • 1. Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites.
    Zhang Y; Chen M; Yu Y; Liu X; Liu W; Jiang L; Zhang W
    J Cutan Pathol; 2022 Feb; 49(2):187-190. PubMed ID: 34622970
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Wang M; Kibbi N; Ring N; Siddon A; Foss F; Totonchy M
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31570354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of chromosomal translocations of DUSP22 and TP63 in ALK-negative anaplastic large cell lymphoma by fluorescence in situ hybridization and related clinical relevance].
    Wang C; Chen X; Chen XY; He YH
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):791-795. PubMed ID: 31594044
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma.
    Yuan CT; Cheng AL; Hou HA
    Virchows Arch; 2023 Mar; 482(3):641-645. PubMed ID: 35984488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous anaplastic large cell lymphoma with DUSP22-IRF4 rearrangement demonstrating a biphasic histopathologic pattern and a complete natural regression.
    Kitajima Y; Yamashina M; Hanamoto M; Shijimaya T; Terai S; Nakamaru S; Makimura K; Inoue N; Takeuchi K; Kiyohara T
    J Dermatol; 2022 Sep; 49(9):e309-e310. PubMed ID: 35560037
    [No Abstract]   [Full Text] [Related]  

  • 6. Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement.
    Magaki S; Satyadev R; Chen Z; Yung KS; Vinters HV; Kinney MC; Said JW
    Brain Tumor Pathol; 2022 Jan; 39(1):25-34. PubMed ID: 34791573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
    Parrilla Castellar ER; Jaffe ES; Said JW; Swerdlow SH; Ketterling RP; Knudson RA; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Vasmatzis G; Gibson SE; Ondrejka S; Nicolae A; Grogg KL; Allmer C; Ristow KM; Wilson WH; Macon WR; Law ME; Cerhan JR; Habermann TM; Ansell SM; Dogan A; Maurer MJ; Feldman AL
    Blood; 2014 Aug; 124(9):1473-80. PubMed ID: 24894770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DUSP22 rearrangement in primary cutaneous T cell lymphoma with features intermediate between mycosis fungoides, anaplastic large-cell lymphoma and lymphomatoid papulosis.
    Diaz de la Pinta FJ; Machan S; Manso Alonso R; Carvajal N; Nieves Salgado R; Piris MA; Rodriguez-Pinilla SM
    Histopathology; 2022 Jan; 80(2):446-449. PubMed ID: 34252219
    [No Abstract]   [Full Text] [Related]  

  • 9. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.
    Ravindran A; Feldman AL; Ketterling RP; Dasari S; Rech KL; McPhail ED; Kurtin PJ; Shi M
    Am J Surg Pathol; 2021 Apr; 45(4):550-557. PubMed ID: 33165091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous anaplastic large-cell lymphoma with 6p25.3 rearrangement exhibits a biphasic histopathologic pattern: Two case reports and literature review.
    Xue YN; Wang Z; Sun JF; Chen H
    J Cutan Pathol; 2021 Dec; 48(12):1463-1470. PubMed ID: 34164830
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Qiu L; Tang G; Li S; Vega F; Lin P; Wang SA; Wang W; Iyer SP; Malpica L; Miranda RN; Konoplev S; Tang Z; Fang H; Medeiros LJ; Xu J
    Haematologica; 2023 Jun; 108(6):1604-1615. PubMed ID: 36453104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
    Hapgood G; Ben-Neriah S; Mottok A; Lee DG; Robert K; Villa D; Sehn LH; Connors JM; Gascoyne RD; Feldman AL; Farinha P; Steidl C; Scott DW; Slack GW; Savage KJ
    Br J Haematol; 2019 Aug; 186(3):e28-e31. PubMed ID: 30873584
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement.
    Fratoni S; Trawinska MM; Capalbo A; Bernardini L; Fabbretti M; Martini M; Niscola P; Zhao XF
    Virchows Arch; 2022 Dec; 481(6):975-979. PubMed ID: 35879438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Double-hit" of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative.
    Karube K; Feldman AL
    Blood; 2020 Feb; 135(9):700. PubMed ID: 32106310
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.
    King RL; Dao LN; McPhail ED; Jaffe ES; Said J; Swerdlow SH; Sattler CA; Ketterling RP; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Gibson SE; Ondrejka SL; Nicolae A; Macon WR; Dasari S; Parrilla Castellar E; Feldman AL
    Am J Surg Pathol; 2016 Jan; 40(1):36-43. PubMed ID: 26379151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.
    Boddicker RL; Feldman AL
    Biomark Med; 2015; 9(8):719-22. PubMed ID: 26223379
    [No Abstract]   [Full Text] [Related]  

  • 18. Histopathological features and outcomes of DUSP22 rearrangement in primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.
    Nieto-Benito LM; Parra-Blanco V; Gómez-Navarro Y; Menárguez-Palanca J; Pulido-Pérez A
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e670-e672. PubMed ID: 34014587
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.
    Xing X; Flotte TJ; Law ME; Blahnik AJ; Chng WJ; Huang G; Knudson RA; Ketterling RP; Porcher JC; Ansell SM; Sidhu J; Dogan A; Feldman AL
    Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):580-9. PubMed ID: 25390351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review.
    Niu N; Heberton MM; Tang Z; Aung PP; Nagarajan P; Curry JL; Prieto VG; Torres-Cabala CA; Cho WC
    J Cutan Pathol; 2023 Aug; 50(8):711-716. PubMed ID: 36944579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.